Wet Age-Related Macular Degeneration: Trends in Real-World Treatment Patterns in the United States

An OMNY Health™ Poster

Our objective was to characterize real-world treatment patterns among wet AMD patients in diverse healthcare delivery settings in the United States (US)

On November 6-9, 2022, this poster was on display at ISPOR Europe

Discussion and Conclusions:

  • Results provide insights into real-world treatment patterns for wet AMD within a diverse set of US healthcare settings

  • Bevacizumab has seen a big increase in usage in the last couple of years and was the most utilized treatment observed

  • As new treatments are developed and introduced, future analyses would be helpful to understand uptake of thearpies and prescription patterns among wet AMD patients

Check Out More Events & Webinars…


By continuing to use the site, you agree to the use of cookies. More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below, then you are consenting to this.